Anpario (LON:ANP) Upgraded at Canaccord Genuity Group

Anpario (LON:ANP) was upgraded by investment analysts at Canaccord Genuity Group to a “buy” rating in a note issued to investors on Thursday,London Stock Exchange reports. The firm currently has a GBX 570 price objective on the stock, up from their prior price objective of GBX 457. Canaccord Genuity Group’s price target suggests a potential upside of 22.61% from the company’s previous close.

Separately, Shore Capital Group reissued a “house stock” rating on shares of Anpario in a research report on Monday, January 19th. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of GBX 570.

Anpario Stock Performance

Shares of ANP stock opened at GBX 464.90 on Thursday. The stock’s fifty day simple moving average is GBX 511.68 and its 200-day simple moving average is GBX 496.76. The company has a market capitalization of £78.78 million, a price-to-earnings ratio of 15.64 and a beta of 0.92. The company has a current ratio of 4.32, a quick ratio of 5.16 and a debt-to-equity ratio of 0.22. Anpario has a 1-year low of GBX 286 and a 1-year high of GBX 580.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.